RedHill Biopharma reported $22.22M in Current Liabilities for its fiscal quarter ending in December of 2024.


Current Liabilities Change Date
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 20.58M 420K Jun/2025
Cronos Group USD 37.61M 4.56M Jun/2025
RedHill Biopharma USD 22.22M 993K Dec/2024